Globus Medical Stock Alpha and Beta Analysis

GMED Stock  USD 71.04  1.36  1.95%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Globus Medical. It also helps investors analyze the systematic and unsystematic risks associated with investing in Globus Medical over a specified time horizon. Remember, high Globus Medical's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Globus Medical's market risk premium analysis include:
Beta
0.81
Alpha
(0.15)
Risk
1.64
Sharpe Ratio
(0.13)
Expected Return
(0.22)
Please note that although Globus Medical alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Globus Medical did 0.15  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Globus Medical stock's relative risk over its benchmark. Globus Medical has a beta of 0.81  . As returns on the market increase, Globus Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Globus Medical is expected to be smaller as well. At present, Globus Medical's Price Book Value Ratio is projected to slightly decrease based on the last few years of reporting. The current year's Price Fair Value is expected to grow to 3.89, whereas Enterprise Value Over EBITDA is forecasted to decline to 13.85.
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Globus Medical Backtesting, Globus Medical Valuation, Globus Medical Correlation, Globus Medical Hype Analysis, Globus Medical Volatility, Globus Medical History and analyze Globus Medical Performance.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.

Globus Medical Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Globus Medical market risk premium is the additional return an investor will receive from holding Globus Medical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Globus Medical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Globus Medical's performance over market.
α-0.15   β0.81

Globus Medical expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Globus Medical's Buy-and-hold return. Our buy-and-hold chart shows how Globus Medical performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Globus Medical Market Price Analysis

Market price analysis indicators help investors to evaluate how Globus Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Globus Medical shares will generate the highest return on investment. By understating and applying Globus Medical stock market price indicators, traders can identify Globus Medical position entry and exit signals to maximize returns.

Globus Medical Return and Market Media

The median price of Globus Medical for the period between Sun, Dec 15, 2024 and Sat, Mar 15, 2025 is 83.47 with a coefficient of variation of 6.56. The daily time series for the period is distributed with a sample standard deviation of 5.53, arithmetic mean of 84.35, and mean deviation of 4.25. The Stock received a lot of media exposure during the period.
 Price Growth (%)  
       Timeline  
1
Acquisition by Daniel Scavilla of 30000 shares of Globus Medical at 26.27 subject to Rule 16b-3
12/20/2024
2
Acquisition by Keith Pfeil of 5833 shares of Globus Medical at 49.65 subject to Rule 16b-3
01/14/2025
3
Globus Medical is a Top-Ranked Growth Stock Should You Buy
02/05/2025
4
Stryker sells US spinal implants business
02/12/2025
5
Globus Medical beats Street in Q4, stock dips as analysts question Nevro buy
02/21/2025
6
Is This the Strongest Medical Stock Right Now
02/26/2025
7
Disposition of 7500 shares by Ann Rhoads of Globus Medical at 78.68 subject to Rule 16b-3
02/28/2025
8
If You Invested 100 In This Stock 10 Years Ago, You Would Have This Much Today
03/03/2025
9
1 Mid-Cap Stock to Target This Week and 2 to Avoid
03/04/2025
10
Is Globus Medical, Inc. the Best Medical Technology Stock to Buy According to Analysts
03/05/2025
11
Theres No Escaping Globus Maritime Limiteds Muted Earnings
03/06/2025
12
Globus Spirits Limited Might Not Be As Mispriced As It Looks
03/07/2025
13
Hip Replacement Market Report and Company Analysis 2025-2033 Featuring Smith Nephew, JJ, Integra, Zimmer Biomet, Stryker, B. Braun Melsungen, Globus Medical, Mi...
03/11/2025
14
Disposition of 6746 shares by David Davidar of Globus Medical at 85.0037 subject to Rule 16b-3
03/13/2025

About Globus Medical Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Globus or other stocks. Alpha measures the amount that position in Globus Medical has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2022 2023 2024 (projected)
Days Sales Outstanding77.55117.4980.8
PTB Ratio4.041.512.69

Globus Medical Upcoming Company Events

As portrayed in its financial statements, the presentation of Globus Medical's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Globus Medical's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Globus Medical's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Globus Medical. Please utilize our Beneish M Score to check the likelihood of Globus Medical's management manipulating its earnings.
20th of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Globus Medical

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Globus Medical is a strong investment it is important to analyze Globus Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Globus Medical's future performance. For an informed investment choice regarding Globus Stock, refer to the following important reports:
Check out Globus Medical Backtesting, Globus Medical Valuation, Globus Medical Correlation, Globus Medical Hype Analysis, Globus Medical Volatility, Globus Medical History and analyze Globus Medical Performance.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Globus Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Globus Medical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Globus Medical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...